| Similar Articles |
|---|
 |
The Motley Fool
May 17, 2005
Rich Smith |
Nutraceutical's Secret Ingredient If it's real-world cash you're after, and steady long-term performance in an investment, Nutraceutical just might make for a healthy supplement to your portfolio.   |
The Motley Fool
August 17, 2006 |
Comparing Companies Evaluate your investment candidates carefully -- here's how to start. |
The Motley Fool
August 24, 2011
Seth Jayson |
A Hidden Reason Why the Future Looks Bright for Nutraceutical International Nutraceutical International may display positive inventory divergence, suggesting that management sees increased demand on the horizon. |
The Motley Fool
June 8, 2004 |
Enterprise Value Explained Don't neglect debt and cash when determining a company's price tag. |
The Motley Fool
July 15, 2004 |
When Debt Is Good vs. Bad Debt on a company's balance sheet can have two sides. Companies that can grow without using debt or issuing extra stock are in a more powerful position than others. Still, you needn't balk at the first sight of debt. Just evaluate it carefully. |
The Motley Fool
October 27, 2005 |
Enterprise Value Explained The enterprise value reminds all investors, large and small, that debt is a cost to the business. |
The Motley Fool
May 3, 2006 |
Enterprise Value, Explained Enterprise value (EV) represents a company's economic value -- the minimum someone would have to pay to buy it outright. It's an important number to consider when you're valuing a stock. |
The Motley Fool
December 27, 2005 |
Foolish Fundamentals: Enterprise Value Don't overlook debt and cash when you're valuing a stock. |
The Motley Fool
January 31, 2008
Brian Lawler |
When Nutraceuticals Attack After a failed phase 3 trial, Neurochem plans to market Alzhemed as a nutraceutical supplement. |
